Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gene Therapy for Hemophilia A With a High Expression Factor VIII Transgene in Autologous Hematopoietic Stem Cells

NCT05265767 is registered in ClinicalTrials.gov with Christian Medical College, Vellore, India as lead sponsor.

NCT NCT05265767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05265767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gene Therapy for Hemophilia A With a High Expression Factor VIII Transgene in Autologous Hematopoietic Stem Cells
Lead sponsor
Christian Medical College, Vellore, India
Phase
Phase 1
Overall status
Completed
Start date
April 1, 2022
Completion date
June 28, 2024
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a